Abstract
Progress in areas of research from the field of G protein-coupled receptor (GPCR) signaling now shows that GPCRs are involved in a broad range of cellular regulatory activities. By virtue of widespread distribution and important roles in cell physiology and biochemistry, GPCRs play multiple important roles in clinical medicine. The understanding of how GPCRs interact with G proteins, effectors, as well as other regulatory proteins has enormous implications for clinical medicine. The rapid progress in determining three-dimensional structures of GPCRs, and more recently their regulators and effectors, has illuminated the search for mechanisms of activation and regulation and has allowed structure-based mutagenesis to test these ideas. The structural and mechanistic studies will in the future also provide opportunities to alter those interactions in pathological situations. A compilation of the most relevant research topics about the implication of heterotrimeric G proteins in the etiology of genetics and neurobiology of mood will provide a broad perspective of this potential therapeutic target field. In this chapter, an attempt is made to show how far GPCR research advanced with regard to the genetics of clinical medicine.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hamm HE (1998) The many faces of G protein signaling. J Biol Chem 273:669–672
King N, Hittinger CT, Carroll SB (2003) Evolution of key cell signaling and adhesion protein families predates animal origins. Science 301:361–363
Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996
Insel PA, Tang CM, Hahntow I et al (2007) Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets. Biochim Biophys Acta 1768:994–1005
Okada F, Tokumitsu Y, Ui M (1986) Desensitization of beta-adrenergic receptor-coupled adenylate cyclase in cerebral cortex after in vivo treatment of rats with desipramine. J Neurochem 47:454–459
Rasmussen SG, Choi HJ, Rosenbaum DM et al (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450:383–387
Gilman AG (1987) G proteins: transducers of receptor-generated signals. Annu Rev Biochem 56:615–649
Attwood TK, Findlay JB (1994) Fingerprinting G-protein-coupled receptors. Protein Eng 7:195–203
Foord SM, Bonner TI, Neubig RR et al (2005) International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57:279–288
Kolakowski LF (1994) GCRDb: a G-protein-coupled receptor database. Receptors Channels 2:1–7
Drummond AH (1988) Lithium affects G-protein receptor coupling. Nature 331:388
Bjarnadottir TK, Gloriam DE, Hellstrand SH et al (2006) Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics 88:263–273
Vassilatis DK, Hohmann JG, Zeng H et al (2003) The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A 100:4903–4908
Fredriksson R, Schioth HB (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67:1414–1425
Tfelt-Hansen J, Ferreira A, Yano S et al (2005) Calcium-sensing receptor activation induces nitric oxide production in H-500 Leydig cancer cells. Am J Physiol Endocrinol Metab 288:E1206–E1213
Schott M, Scherbaum WA, Morgenthaler NG (2005) Thyrotropin receptor autoantibodies in Graves’ disease. Trends Endocrinol Metab 16:243–248
Kierszenbaum F (2005) Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol 21:513–516
Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112:7–14
Wallukat G, Nissen E, Morwinski R et al (2000) Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz 25:261–266
Joiner TE, Brown JS, Wingate LR (2005) The psychology and neurobiology of suicidal behavior. Annu Rev Psychol 56:287–314
Isometsa ET, Lonnqvist JK (1998) Suicide attempts preceding completed suicide. Br J Psychiatry 173:531–535
Robins E, Murphy GE, Wilkinson RH et al (1959) Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am J Public Health Nations Health 49:888–899
Cheng AT (1995) Mental illness and suicide. A case–control study in east Taiwan. Arch Gen Psychiatry 52:594–603
Rodriguez-Puertas R, Pascual J, Pazos A (1996) Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study in control and Alzheimer’s disease brain tissues. Brain Res 728:65–71
Balazs J, Lecrubier Y, Csiszer N et al (2003) Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: importance of the first depressive episodes and of bipolar II diagnoses. J Affect Disord 76:113–119
Henriksson MM, Aro HM, Marttunen MJ et al (1993) Mental disorders and comorbidity in suicide. Am J Psychiatry 150:935–940
Ramakrishna D, Subhas MN (2010) Differential modulation of alpha-1 adrenoceptor subtypes by antidepressants in the rat brain. J Neural Transm 117:1423–1430
Bunney WE, Davis JM (1965) Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry 13:483–494
Coppen A (1969) Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes. Psychiatr Neurol Neurochir 72:173–180
Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522
Devaki R, Shankar RS, Nadgir SM (2006) The effect of lithium on the adrenoceptor-mediated second messenger system in the rat brain. J Psychiatry Neurosci 31:246–252
Subhash MN, Nagaraja MR, Sharada S et al (2003) Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain. Neurochem Int 43:603–609
Ramakrishna D, Subash MN, Sharada S et al (2004) Modulation of α1-adrenoceptors by tricyclic antidepressants in rat brain. J Neurochem 88:77
Narendra Sharath Chandra JN, Manish M, Sadashiva CT et al (2008) Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer’s dementia models. Neurochem Int 52:376–383
Escriba PV, Ozaita A, Garcia-Sevilla JA (2004) Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 29:1512–1521
Gabilondo AM, Meana JJ, Garcia-Sevilla JA (1995) Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res 682:245–250
Hungund BL, Vinod KY, Kassir SA et al (2004) Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 9:184–190
Wong ML, Licinio J (2004) From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3:136–151
Lesch KP, Aulakh CS, Tolliver TJ et al (1991) Regulation of G proteins by chronic antidepressant drug treatment in rat brain: tricyclics but not clorgyline increase Go alpha subunits. Eur J Pharmacol 207:361–364
Lesch KP, Manji HK (1992) Signal-transducing G proteins and antidepressant drugs: evidence for modulation of alpha subunit gene expression in rat brain. Biol Psychiatry 32:549–579
Delgado PL, Charney DS, Price LH et al (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411–418
Menkes DB, Rasenick MM, Wheeler MA et al (1983) Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment. Science 219:65–67
Avissar S, Schreiber G, Danon A et al (1988) Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331:440–442
Colin SF, Chang HC, Mollner S (1991) Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex. Proc Natl Acad Sci U S A 88:10634–10637
Lesch KP, Aulakh CS, Tolliver TJ et al (1991) Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brain. Eur J Pharmacol 207:355–359
Acknowledgments
Author declares that there is no competing of interests. The author is grateful to Kamineni Institute of Medical Sciences for constant encouragement and support.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Devaki, R. (2014). Importance of G Protein-Coupled Receptor Genetics in Clinical Medicine. In: Stevens, C. (eds) G Protein-Coupled Receptor Genetics. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-779-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-62703-779-2_15
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-778-5
Online ISBN: 978-1-62703-779-2
eBook Packages: Springer Protocols